• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病患者深静脉血栓形成和肺栓塞的发病率:一项基于人群的队列研究。

The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.

作者信息

Bernstein C N, Blanchard J F, Houston D S, Wajda A

机构信息

Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.

出版信息

Thromb Haemost. 2001 Mar;85(3):430-4.

PMID:11307809
Abstract

BACKGROUND

There is an impression mostly from specialty clinics that patients with inflammatory bowel disease (IBD) have an increased risk of venous thromboembolic disorders. Our aim was to determine the incidence of deep venous thrombosis (DVT) and pulmonary embolism (PE) from a population-based database of IBD patients and, to compare the incidence rates to that of an age, gender and geographically matched population control group.

METHODS

IBD patients identified from the administrative claims data of the universal provincial insurance plan of Manitoba were matched 1:10 to randomly selected members of the general population without IBD by year, age, gender, and postal area of residence using Manitoba Health's population registry. The incidence of hospitalization for DVT and PE was calculated from hospital discharge abstracts using ICD-9-CM codes 451.1, 453.x for DVT and 415.1x for PE. Rates were calculated based on person-years of follow-up for 1984-1997. Comparisons to the population cohort yielded age-adjusted incidence rate ratios (IRR). Rates were calculated based on person-years of follow-up (Crohn's disease = 21,340, ulcerative colitis = 19,665) for 1984-1997.

RESULTS

In Crohn's disease the incidence rate of DVT was 31.4/10,000 person-years and of PE was 10.3/10,000 person-years. In ulcerative colitis the incidence rates were 30.0/10,000 person-years for DVT and 19.8/10,000 person-years for PE. The IRR was 4.7 (95% CI, 3.5-6.3) for DVT and 2.9 (1.8-4.7) for PE in Crohn's disease and 2.8 (2.1-3.7) for DVT and 3.6 (2.5-5.2) for PE, in ulcerative colitis. There were no gender differences for IRR. The highest rates of DVT and PE were seen among patients over 60 years old; however the highest IRR for these events were among patients less than 40 years.

CONCLUSION

IBD patients have a threefold increased risk of developing DVT or PE.

摘要

背景

大多来自专科诊所的印象是,炎症性肠病(IBD)患者发生静脉血栓栓塞性疾病的风险增加。我们的目的是从一个基于人群的IBD患者数据库中确定深静脉血栓形成(DVT)和肺栓塞(PE)的发病率,并将发病率与年龄、性别和地理位置匹配的人群对照组进行比较。

方法

从曼尼托巴省全民省级保险计划的行政索赔数据中识别出的IBD患者,通过曼尼托巴省卫生部门的人口登记系统,按年份、年龄、性别和居住邮政区域与随机选择的无IBD的普通人群成员以1:10的比例进行匹配。使用ICD-9-CM编码451.1、453.x表示DVT,415.1x表示PE,从医院出院摘要中计算DVT和PE的住院发病率。发病率基于1984 - 1997年的随访人年数计算。与人群队列的比较得出年龄调整发病率比(IRR)。发病率基于1984 - 1997年的随访人年数计算(克罗恩病 = 21,340,溃疡性结肠炎 = 19,665)。

结果

在克罗恩病中,DVT的发病率为31.4/10000人年,PE的发病率为10.3/10000人年。在溃疡性结肠炎中,DVT的发病率为30.0/10000人年,PE的发病率为19.8/10000人年。克罗恩病中DVT的IRR为4.7(95%CI,3.5 - 6.3),PE为2.9(1.8 - 4.7);溃疡性结肠炎中DVT的IRR为2.8(2.1 - 3.7),PE为3.6(2.5 - 5.2)。IRR没有性别差异。DVT和PE的最高发病率出现在60岁以上的患者中;然而,这些事件的最高IRR出现在40岁以下的患者中。

结论

IBD患者发生DVT或PE的风险增加了两倍。

相似文献

1
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.炎症性肠病患者深静脉血栓形成和肺栓塞的发病率:一项基于人群的队列研究。
Thromb Haemost. 2001 Mar;85(3):430-4.
2
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.丹麦炎症性肠病儿童和成人的血栓栓塞风险:一项基于人群的全国性研究。
Gut. 2011 Jul;60(7):937-43. doi: 10.1136/gut.2010.228585. Epub 2011 Feb 21.
3
The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.炎症性肠病中动脉血栓栓塞性疾病的发病率:一项基于人群的研究。
Clin Gastroenterol Hepatol. 2008 Jan;6(1):41-5. doi: 10.1016/j.cgh.2007.09.016. Epub 2007 Dec 11.
4
Inflammatory bowel disease increases the risks of deep vein thrombosis and pulmonary embolism in the hospitalized patients: a nationwide cohort study.炎症性肠病增加住院患者深静脉血栓形成和肺栓塞的风险:一项全国性队列研究。
Thromb Res. 2015 Mar;135(3):492-6. doi: 10.1016/j.thromres.2014.12.025. Epub 2015 Jan 7.
5
Increased risk of postoperative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease: a study of National Surgical Quality Improvement Program patients.炎症性肠病患者术后深静脉血栓形成和肺栓塞风险增加:一项针对国家外科质量改进计划患者的研究
Arch Surg. 2012 Feb;147(2):120-4. doi: 10.1001/archsurg.2011.297. Epub 2011 Oct 17.
6
Pulmonary embolism: which pediatric trauma patients are at risk?肺栓塞:哪些儿科创伤患者有风险?
J Pediatr Surg. 2005 Jan;40(1):124-7. doi: 10.1016/j.jpedsurg.2004.09.017.
7
Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease.日本炎症性肠病患者静脉血栓栓塞及凝血-纤溶标志物的评估
J Gastroenterol. 2004 Oct;39(10):948-54. doi: 10.1007/s00535-004-1426-6.
8
Increased risk for demyelinating diseases in patients with inflammatory bowel disease.炎症性肠病患者患脱髓鞘疾病的风险增加。
Gastroenterology. 2005 Sep;129(3):819-26. doi: 10.1053/j.gastro.2005.06.022.
9
Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study.人体身高与静脉血栓栓塞发生率的性别差异:一项丹麦随访研究。
Eur J Intern Med. 2010 Aug;21(4):268-72. doi: 10.1016/j.ejim.2010.03.013. Epub 2010 Apr 28.
10
The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.炎症性肠病中其他慢性炎症性疾病的聚集性:一项基于人群的研究。
Gastroenterology. 2005 Sep;129(3):827-36. doi: 10.1053/j.gastro.2005.06.021.

引用本文的文献

1
Utility of rotational thrombo-elastometry as an objective measure of hypercoagulability in ulcerative colitis.旋转血栓弹力图作为溃疡性结肠炎高凝状态客观指标的效用
Indian J Gastroenterol. 2025 Apr 26. doi: 10.1007/s12664-025-01759-7.
2
Cardiac arrhythmia in patients with inflammatory bowel disease: a retrospective, population-based cohort study in Manitoba, Canada.炎症性肠病患者的心律失常:加拿大曼尼托巴省一项基于人群的回顾性队列研究。
BMJ Open. 2025 Mar 21;15(3):e097687. doi: 10.1136/bmjopen-2024-097687.
3
Pulmonary Manifestations of IBD: Case Report and Review of the Literature.
炎症性肠病的肺部表现:病例报告及文献综述
J Clin Med. 2024 Sep 12;13(18):5401. doi: 10.3390/jcm13185401.
4
Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure.在接受药物治疗长达 9.2 年的全球临床开发项目中,对托法替布治疗溃疡性结肠炎的安全性进行分析。
United European Gastroenterol J. 2024 Jul;12(6):793-801. doi: 10.1002/ueg2.12584. Epub 2024 May 22.
5
Prevalence of Classical Extraintestinal Manifestations among Inflammatory Bowel Disease Patients in Saudi Arabia: A Single Tertiary Center Experience.沙特阿拉伯炎症性肠病患者中经典肠外表现的患病率:单中心三级医院经验
Saudi J Med Med Sci. 2024 Apr-Jun;12(2):169-174. doi: 10.4103/sjmms.sjmms_139_23. Epub 2024 Apr 5.
6
Case Report: A case of Crohn's disease with right atrial thrombosis.病例报告:一例克罗恩病合并右心房血栓形成。
Front Pediatr. 2024 Mar 21;12:1353883. doi: 10.3389/fped.2024.1353883. eCollection 2024.
7
Tofacitinib use in ulcerative colitis: An expert consensus for day-to-day clinical practice.托法替布在溃疡性结肠炎中的应用:日常临床实践专家共识
Indian J Gastroenterol. 2024 Feb;43(1):22-35. doi: 10.1007/s12664-023-01507-9. Epub 2024 Feb 12.
8
Standard and Extended Thromboprophylaxis in Patients with Inflammatory Bowel Disease: A Literature Review.炎症性肠病患者的标准和延长血栓预防:文献综述
Euroasian J Hepatogastroenterol. 2023 Jul-Dec;13(2):133-141. doi: 10.5005/jp-journals-10018-1401.
9
Venous Thromboembolism in Patients with Inflammatory Bowel Disease.炎症性肠病患者的静脉血栓栓塞
J Clin Med. 2023 Dec 31;13(1):251. doi: 10.3390/jcm13010251.
10
Total flavones from ameliorate colitis by adjusting the gut microbiota.总黄酮通过调节肠道微生物群改善结肠炎。
Ann Med. 2023;55(2):2292246. doi: 10.1080/07853890.2023.2292246. Epub 2023 Dec 13.